Showing results (41-50 of 87) with videos related to
Sort By:
Pageof 9
Medical Oncology (Northwood, London, England)|March 6, 2014
Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancerAhmet Dirican, Yuksel Kucukzeybek, Ahmet Alacacioglu, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2015
Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: an Izmir Oncology Group (IZOG) studyTarik Salman, Elif Yildiz, Ibrahim Yildiz, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 26, 2018
Is adjuvant chemotherapy necessary for Luminal A-like breast cancer?Halil Taskaynatan, Yuksel Kucukzeybek, Ahmet Alacacioglu, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2019
High expression of mesothelin in advanced serous ovarian cancer is associated with poor prognosisYasar Yildiz, Gokhan Kabadayi, Seyran Yigit, et al.Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|June 12, 2023
The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinomaUmut Varol, Ebru Cakır, Safiye Aktas, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 1, 2017
Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitorTarik Salman, Leyla Demir, Umut Varol, et al.Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|October 24, 2018
Prognostic significance of androgen receptor expression in HER2-positive and triple-negative breast cancerBetul Bolat Kucukzeybek, Ibrahım V Bayoglu, Yuksel Kucukzeybek, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 27, 2015
Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancerIbrahim Vedat Bayoglu, Ibrahim Yildiz, Umut Varol, et al.Journal of Laboratory Physicians|December 1, 2018
Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?Serife Solmaz, Ozcan Uzun, Celal Acar, et al.Breast (Edinburgh, Scotland)|March 16, 2005
Primary non-hodgkin lymphoma of breast in a patient with rectal carcinoma and magnetic resonance spectroscopic examinationBinnaz Demirkan, Pinar Balci, Mehmet A Ozcan, et al.Pageof 9